Cargando…
Immune Suppression Therapy in Aplastic Anemia: Influencing Factors on Response and Survival
OBJECTIVES: Immune suppresion(IS) therapy has provided another opportunity of cure or improvement in the aplastic anemia patients who cannot receive bone marrow transplanatation due to many causes. There are a few reports regardig the factors that affect response, survial and prognosis after IS ther...
Autores principales: | Jin, Jong Youl, Kim, Dong Wook, Lee, Jong Wook, Han, Chi Wha, Min, Woo Sung, Park, Chong Won, Kim, Chun Choo, Kim, Dong Jip, Kim, Hack Ki, Song, Hae Hiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532026/ https://www.ncbi.nlm.nih.gov/pubmed/7626553 http://dx.doi.org/10.3904/kjim.1995.10.1.25 |
Ejemplares similares
-
Immunomodulation Therapy for Severe Aplastic Anemia: —ALG Versus ALG Plus Cyclosporin A—
por: Park, Chong Won, et al.
Publicado: (1989) -
Very Severe Aplastic Anemia appearing after Thymectomy
por: Park, Chi Young, et al.
Publicado: (2003) -
A Case of Focal Segmental Glomerulosclerosis Associated with Aplastic Anemia
por: Park, Chi Young, et al.
Publicado: (2004) -
Recent advances in treatment of aplastic anemia
por: Shin, Seung Hwan, et al.
Publicado: (2014) -
Mitochondrial DNA Aberrations of Bone Marrow Cells from Patients with Aplastic Anemia
por: Kim, Hye-Ran, et al.
Publicado: (2008)